DrugsControl Media Services

News Detail

MDC to seek clarity on licensing requirement for drug device combination (08-07-2024)

New Delhi, 8 July 2024: The Multidisciplinary Committee of Experts (MDC), which advices the National Pharmaceutical Pricing Authority (NPPA), will be seeking clarity from the central drug regulator on the licensing requirement of a drug device combination of Cipla in order to det......
View Details

Source : Pharmabiz
Multidisciplinary Committee of Experts MDC NPPA central drug regulator drug device combination Cipla Ciphaler inhaler device dry powder inhaler DPI formoterol fumarate budesonide Turbuhaler AstraZeneca CDSCO Synchro breath inhaler device

Related News